Medscape LIVE EVENT: Changing Neoadjuvant and Adjuvant Paradigms in HER2-Positive Breast Cancer What Surgeons Need to Know
FRIDAY, 16 OCTOBER 2020 | 12:30 – 13:30 CEST
Participants can access this live virtual event on Friday, October 16, 2020, from 12:30 – 13:30 CEST. Join here
Join our expert faculty as they discuss therapeutic approaches for patients with HER2-positive early breast cancer. The latest evidence and rationale for neoadjuvant and adjuvant treatment strategies will be discussed, as well as optimal application in routine practice. What do surgeons need to know? Please come with your most pressing questions.